Search clinical trials for: Raloxifene hydrochloride
Total 7371 results
-
Paula Silverman, MDNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Sihuan Pharmaceutical Holdings Group Ltd.Completed
-
NCIC Clinical Trials GroupCompletedPancreatic CancerUnited States, Canada, Australia, Singapore, Belgium, United Kingdom, Israel, New Zealand, China, Germany, Brazil, Poland, Italy, Argentina, Romania, Greece, Chile, Hong Kong, Mexico
-
Roswell Park Cancer InstituteCompletedEsophageal CancerUnited States
-
University College, LondonRoche Pharma AG; Cancer Research UKCompletedLung CancerUnited Kingdom
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes MellitusUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Japan Multinational Trial OrganizationCompleted
-
Shandong Lanjin Pharmaceuticals Co.,LtdUnknownNeoplasms | Leukemia | Chronic Lymphocytic LeukemiaChina
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
University of ChicagoNational Cancer Institute (NCI)CompletedMalignant Peritoneal MesotheliomaUnited States
-
Taro Pharmaceuticals USATerminated
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Hodgkin Lymphoma | Recurrent Adult T-cell Leukemia/Lymphoma and other conditionsUnited States
-
National Cancer Institute (NCI)WithdrawnExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone LymphomaUnited States
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage II Pancreatic CancerUnited States
-
Mayo ClinicNational Comprehensive Cancer NetworkCompletedStage III Gallbladder Cancer AJCC v8 | Stage IIIA Gallbladder Cancer AJCC v8 | Stage IIIB Gallbladder Cancer AJCC v8 | Refractory Gallbladder Carcinoma | Stage IV Gallbladder Cancer AJCC v8 | Stage IV Distal Bile Duct Cancer AJCC v8 | Stage IV Intrahepatic Bile Duct Cancer AJCC v8 | Stage IVB Gallbladder... and other conditionsUnited States
-
Laboratoires TheaActive, not recruitingOcular Hypertension | GlaucomaUnited States
-
TelikTerminatedSevere Chronic NeutropeniaUnited States
-
National Cancer Institute (NCI)Active, not recruitingSolid NeoplasmUnited States
-
AmgenCompletedNon-Hodgkin's LymphomaUnited States, Australia, Italy, United Kingdom, Germany, France
-
Brigham and Women's HospitalCompletedErythropoietic Protoporphyria
-
CephalonCompletedNon-Hodgkin's Lymphoma (NHL)United States, Belgium, Israel
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSmall Cell Lung CarcinomaChina
-
Sumitomo Pharma Co., Ltd.TerminatedSmall-cell Lung CancerJapan
-
University Health Network, TorontoCompletedPancreatic CancerCanada
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
BioCryst PharmaceuticalsCompletedLeukemia, Lymphocytic, ChronicUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingDuctal Breast Carcinoma in Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Atypical Ductal Breast Hyperplasia | Lobular Breast Carcinoma in SituUnited States
-
Aziende Chimiche Riunite Angelini Francesco S.p.AZak-Pharma Dienstleistung Ges.m.b.H.CompletedAcute Sore ThroatHungary, Poland, Russian Federation
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Completed
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
AllerdermCompleted
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Completed
-
NCIC Clinical Trials GroupGlaxoSmithKlineCompleted
-
Merck Sharp & Dohme LLCCompletedNon-alcoholic Fatty Liver Disease
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaGermany
-
Centre Antoine LacassagneCompletedPancreatic CancerFrance
-
University of California, DavisNational Cancer Institute (NCI); Novartis PharmaceuticalsCompletedRecurrent Non-small Cell Lung CancerUnited States
-
Menzies School of Health ResearchCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma Inc; OSI PharmaceuticalsCompletedPancreatic CancerUnited States, Canada
-
Northwestern UniversityGenentech, Inc.; Amgen; OSI PharmaceuticalsCompleted
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruiting
-
National Cancer Institute (NCI)CompletedBreast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerCanada
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Unknown